Characterization of a large outbreak by CTX-M-1-producing Klebsiella pneumoniae and mechanisms leading to in vivo carbapenem resistance development

被引:117
作者
Mena, Ana
Plasencia, Virginia
Garcia, Laura
Hidalgo, Olga
Ignacio Ayestaran, Jose
Alberti, Sebastian
Borrell, Nuria
Perez, Jose L.
Oliver, Antonio
机构
[1] Hosp Son Dureta, Microbiol Serv, Palma de Mallorca 07014, Spain
[2] Univ Islas Baleares, Inst Univ Invest Ciencias Salud, Palma de Mallorca, Spain
[3] Univ Islas Baleares, Area Microbiol, Palma de Mallorca, Spain
[4] Hosp Son Dureta, Serv Med Prevent, Palma de Mallorca, Spain
[5] Hosp Son Dureta, Serv Med Intens, Palma de Mallorca, Spain
关键词
D O I
10.1128/JCM.00418-06
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
All extended-spectrum beta-lactamase (ESBL) -producing Enterobacteriaceae isolates from patients admitted to and adult intensive care unit were prospectively documented from 2002 to 2005, when a large outbreak (51 patients affected) of multiresistant ESBL-producing Klebsiella pneumoniae infection was detected. The involvement of a single K. pneumoniae clone was demonstrated by pulsed-held gel electrophoresis. In addition to the ESBL-mediated resistance, the epidemic strain uniformly showed cross-resistance to ciprofloxacin, gentamicin, tobramycin, trimethoprim-sulfamethoxazole, and tetracycline, whereas resistance to the beta-lactam-beta-lactamase inhibitor combinations was variable. The ESBL involved was CTX-M-1, as demonstrated by isoelectric focusing, PCR amplification, and sequencing. CTX-M-1 as well as the aminoglycoside resistance determinants were encoded in a 50-kb plasmid that could be transferred to Escherichia coli only by transformation. In two of the infected patients, carbapenem resistance development (MICs of 8 to 12, 16, and >32 mu g/ml for imipenem, meropenem, and ertapenem, respectively) was documented, both in clinical samples and in intestinal colonization studies. The analysis of the outer membrane proteins of the carbapenem-susceptible and -resistant isolates revealed that the former expressed only one of the two major porins, OmpK36, whereas the latter did not express either of them. In one of the cases, the lack of expression of OmpK36 was demonstrated to be mediated by the interruption of the coding sequence by the insertion sequence IS26. This is the first report of a large outbreak of CTX-M-1 -producing Enterobacteriaceae and, curiously, the first documented description in the literature of CTX-M-1 in K. pneumoniae, despite the fact that this enzyme has been found in multiple species. Furthermore, we document and characterize for the first time carbapenem resistance development in CTX-M-1 -producing Enterobacteriaceae.
引用
收藏
页码:2831 / 2837
页数:7
相关论文
共 39 条
[1]  
ALBERTI S, 1995, INFECT IMMUN, V63, P903
[2]   A NEW PLASMIDIC CEFOTAXIMASE IN A CLINICAL ISOLATE OF ESCHERICHIA-COLI [J].
BAUERNFEIND, A ;
GRIMM, H ;
SCHWEIGHART, S .
INFECTION, 1990, 18 (05) :294-298
[3]   Growing group of extended-spectrum β-lactamases:: The CTX-M enzymes [J].
Bonnet, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (01) :1-14
[4]   Imipenem resistance of Enterobacter aerogenes mediated by outer membrane permeability [J].
Bornet, C ;
Davin-Regli, A ;
Bosi, C ;
Pages, JM ;
Bollet, C .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (03) :1048-1052
[5]   Extended-spectrum β-lactamases in the 21st century:: Characterization, epidemiology, and detection of this important resistance threat [J].
Bradford, PA .
CLINICAL MICROBIOLOGY REVIEWS, 2001, 14 (04) :933-951
[6]   Monitoring and characterization of extended-spectrum β-lactamases in Escherichia coli strains from healthy and sick animals in Spain in 2003 [J].
Briñas, L ;
Moreno, MA ;
Teshager, T ;
Sáenz, Y ;
Porrero, MC ;
Domínguez, L ;
Torres, C .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (03) :1262-1264
[7]   A FUNCTIONAL CLASSIFICATION SCHEME FOR BETA-LACTAMASES AND ITS CORRELATION WITH MOLECULAR-STRUCTURE [J].
BUSH, K ;
JACOBY, GA ;
MEDEIROS, AA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (06) :1211-1233
[8]  
Cantón R, 2000, J CLIN MICROBIOL, V38, P1339
[9]   Emergence of imipenem resistance in Klebsiella pneumoniae owing to combination of plasmid-mediated CMY-4 and permeability alteration [J].
Cao, VTB ;
Arlet, G ;
Ericsson, BM ;
Tammelin, A ;
Courvalin, P ;
Lambert, T .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (06) :895-900
[10]   Genes encoding TEM-4, SHV-2, and CTX-M-10 extended-spectrum β-lactamases are carried by multiple Klebsiella pneumoniae clones in a single hospital (Madrid, 1989 to 2000) [J].
Coque, TM ;
Oliver, A ;
Pérez-Díaz, C ;
Baquero, F ;
Cantón, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (02) :500-510